Biomerica (BMRA) Operating Margin (2010 - 2026)

Biomerica has disclosed Operating Margin across 17 years of filings, most recently posting 131.51% for Q1 2026.

• Operating Margin for Q1 2026 came in at 131.51%, down 2338.0% year-over-year; the trailing twelve-month figure through Feb 2026 was 123.74% (down 16803.0% YoY), and the FY2025 annual result was 96.72%, down 11975.0% from the prior year.
• Operating Margin came in at 131.51% for Q1 2026 at Biomerica, down from 113.47% in the prior quarter.
• In the past five years, Operating Margin ranged from a high of 545.34% in Q2 2024 to a low of 208.81% in Q2 2025.
• The 5-year median for Operating Margin is 108.13% (2025), against an average of 70.17%.
• Across the five-year window, Operating Margin jumped 71104 bps in 2024 and tumbled 75415 bps in 2025, its largest moves.
• Biomerica's Operating Margin stood at 112.42% in 2022, then rose by 9 bps to 102.62% in 2023, then surged by 41 bps to 60.7% in 2024, then plunged by 87 bps to 113.47% in 2025, then decreased by 16 bps to 131.51% in 2026.
• The last three Operating Margin figures came in at 131.51% (Q1 2026), 113.47% (Q4 2025), and 81.01% (Q3 2025), per Business Quant data.